Determining economic feasibility of fluticasone propionate-salmeterol vs montelukast in the treatment of persistent asthma using a net benefit approach and cost-effectiveness acceptability curves

Authors:
  • AEAmanda Emmett
    Amanda Emmett
  • PJPriti Jhingran
    Priti Jhingran
  • KRKathleen Rickard
    Kathleen Rickard
  • PDPaul Dorinsky
    Paul Dorinsky

Abstract
No abstract available

This publication has 22 references indexed in Scilit: